Jupiter Wellness Reports Efficacy Results From Clinical Study For Its NoStingz Topical Jellyfish Protection Sunscreen
Portfolio Pulse from Benzinga Newsdesk
Jupiter Wellness, Inc. (NASDAQ:JUPW) announced positive results from a clinical study of its proprietary sunscreen, NoStingz, which is formulated to protect users from jellyfish stings, sea lice, and UVA/UVB rays. The study showed that NoStingz significantly reduced pain from jellyfish stings compared to other sunscreens and untreated skin. The company plans to use these results to expand sales channels for NoStingz and make further advancements in its sunscreen and skincare product lines.
August 09, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The positive results from the clinical study of NoStingz could boost Jupiter Wellness's sales and revenue, potentially leading to a positive impact on its stock price.
The positive results from the clinical study of NoStingz, a product of Jupiter Wellness, could lead to increased sales and revenue for the company. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100